Such competition will put a lot of pressure on prices in the years to come
Build context before evaluating a research material
Exenatide is available in both immediate-release (2.4-h half-life, twice-daily dosing) and extended-release formulations (approximately 2-week half-life with multiphasic profile) [27]
These side effects are more likely to occur at the start of treatment or after a dose increase
The 2.5 mg dose is better called the low-dose starter, because it is the labeled start and now has short direct non-diabetic data behind it. Microdosing has been used for tolerability testing, metabolic-marker support, step-down protocols, and maintenance, not for proven long-term obesity outcomes
Persistent flushing, flushing accompanied by other symptoms, or a reaction that becomes more intense should be discussed with the prescribing provider